Spire Healthcare Group (LON:SPI) Shares Down 16.3% – Time to Sell?

Spire Healthcare Group plc (LON:SPI) traded down 16.3% on Thursday . The company traded as low as GBX 169 ($2.18) and last traded at GBX 188 ($2.42). 4,929,258 shares changed hands during mid-day trading, an increase of 648% from the average session volume of 658,925 shares. The stock had previously closed at GBX 224.50 ($2.89).

Spire Healthcare Group Stock Down 16.3 %

The firm has a market capitalization of £754.90 million, a price-to-earnings ratio of 26.76, a P/E/G ratio of 1.06 and a beta of 0.96. The stock has a fifty day moving average of GBX 229.09 and a two-hundred day moving average of GBX 230.72. The company has a debt-to-equity ratio of 62.25, a current ratio of 0.70 and a quick ratio of 0.74.

Spire Healthcare Group (LON:SPI) last posted its quarterly earnings data on Thursday, March 6th. The company reported GBX 8.80 ($0.11) earnings per share for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. Sell-side analysts anticipate that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.